NHI Stock Analysis: Buy, Sell, or Hold?
NHI - National Health Investors
$82.12
1.35 (1.67%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
23d
Get Alerted When NHI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NHI shows positive signals but monitor for confirmation. Market pricing in 1.3% growth. Moderate conviction.
💡 BUY OPPORTUNITY: NHI shows positive signals but monitor for confirmation. Market pricing in 1.3% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$114.10
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$70.84
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NHI is currently trading at $82.12, which is considered extended relative to its 30-day fair value range of $76.79 to $80.08. The stock's valuation (Forward PE: 24.1) is in line with its historical norms (23.2). At these levels, the market is pricing in 1.3% annual earnings growth.
Technical Outlook: Technically, NHI is in a uptrend. The price is approaching resistance at $81.48. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NHI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (3th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NHI is in a uptrend. The price is approaching resistance at $81.48. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NHI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (3th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$76.79 -
$80.08
Company Quality Score
65/100
(BUY)
Options IV Signal
3th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
68.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 3th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($85.62)
- BULLISH: Expecting earnings turnaround to 1.3% growth with -11.7% revenue growth
Fair Price Analysis
30-Day Fair Range
$76.79 -
$80.08
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$2.60
(3.2%)
Support & Resistance Levels
Support Level
$77.97
Resistance Level
$81.48
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
24.09
Wall Street Target
$85.63
(+6.0%)
Revenue Growth (YoY)
-11.7%
Earnings Growth (YoY)
-14.1%
Profit Margin
41.2%
Valuation Premium vs History
+1.3% premium
PE vs Historical
24.1 vs 23.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.3%
(market-implied from PE analysis)
1-Year Target
$81.82
(+1%)
2-Year Target
$82.88
(+3%)
3-Year Target
$83.96
(+4%)
3-Yr Target (if PE normalizes)
(PE: 24→23)
PE COMPRESSION
$80.86
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.1, Growth: 12.0%)
$113.48
(+41%)
Base:
(SPY PE: 22.3, Growth: 12.0%)
$105.05
(+30%)
Bear:
(PE: 19.0, Growth: 12.0%)
$89.29
(+11%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 24.63 | Current EPS (TTM): $3.18
Bull Case
$90.85
(+11%)
Analyst growth 5.4%, PE expands to 27.1
Base Case
$82.59
(+1%)
Market implied 5.4%, PE stable at 24.6
Bear Case
$53.26
(-35%)
Severe decline -20.0%, PE contracts to 20.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 2:37 PM ET
Data refreshes hourly during market hours. Next update: 3:37 PM
Data refreshes hourly during market hours. Next update: 3:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NHI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$86 | 59 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$209 | 62 BUY |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$20 | 54 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$14 | 57 HOLD |
|
AHR
American Healthcare REIT… |
STRONG BUY
9 analysts |
$56 | 54 HOLD |
Advanced NHI Option Strategies
Professional options setups generated by AI based on today's NHI price and gamma walls.
